April 13, 2018
Rose
It's the first screening device the FDA has authorized that doesn't need a clinician's interpretation to look for a particular condition. In other news, the agency also is going to relax its review of next-generation sequencing tests.
from Kaiser Health News https://ift.tt/2vb5cKf
April 13, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Savvy Patient Fought for the Price She Was Quoted − And Didn’t Give Up- Scientists Warn Americans Are Expecting Too Much From a Vaccine
- As Anxieties Rise, Californians Buy Hundreds of Thousands More Guns
- For Each Critically Ill COVID Patient, a Family Is Suffering, Too
- Readers and Tweeters Shed Light on Vaccine Trials and Bias in Health Care
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment